Stay updated on Atrasentan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.

Latest updates to the Atrasentan in IgA Nephropathy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check16 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the normal study-record content with an access-denied message and the site footer.SummaryDifference0.5%

- Check23 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an access-denied notice. The header/navigation remains visible, indicating restricted access to the page.SummaryDifference19%

- Check30 days agoChange DetectedThe page now displays revision v3.7.0, replacing the previous v3.6.6 tag. This indicates a metadata/version update rather than a change to study information.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6. This represents a new release of the page content, typically including small edits or fixes.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page footer now displays Revision: v3.6.5, replacing the previous v3.6.4. This reflects a software version update rather than a modification to the study details.SummaryDifference0.0%

Stay in the know with updates to Atrasentan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.